Barrow Hanley Mewhinney & Strauss LLC Spectrum Pharmaceuticals Inc Transaction History

Barrow Hanley Mewhinney & Strauss LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 09, 2018	SELL	$13.36 - $20.73 $3.1 Million - $4.8 Million	-231,745 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$8.75 - $14.07 $2.03 Million - $3.26 Million	231,745	231,745 $3.26 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.